[HTML][HTML] The impact of epidermal growth factor receptor mutations on the prognosis of resected non-small cell lung cancer: a meta-analysis of literatures
Q He, P Xin, M Zhang, S Jiang, J Zhang… - Translational Lung …, 2019 - ncbi.nlm.nih.gov
Background Epidermal growth factor receptor (EGFR) mutation represents a good response
to EGFR-tyrosine kinase inhibitor and an advantageous prognostic factor in advanced-stage …
to EGFR-tyrosine kinase inhibitor and an advantageous prognostic factor in advanced-stage …
The impact of epidermal growth factor receptor mutations on the prognosis of resected non-small cell lung cancer: a meta-analysis of literatures
Q He, P Xin, M Zhang, S Jiang, J Zhang… - Translational Lung …, 2019 - tlcr.amegroups.org
Background: Epidermal growth factor receptor (EGFR) mutation represents a good response
to EGFR-tyrosine kinase inhibitor and an advantageous prognostic factor in advanced-stage …
to EGFR-tyrosine kinase inhibitor and an advantageous prognostic factor in advanced-stage …
[PDF][PDF] The impact of epidermal growth factor receptor mutations on the prognosis of resected non-small cell lung cancer: a meta-analysis of literatures
Q He, P Xin, M Zhang, S Jiang, J Zhang, S Zhong, Y Liu… - researchgate.net
Background: Epidermal growth factor receptor (EGFR) mutation represents a good response
to EGFR-tyrosine kinase inhibitor and an advantageous prognostic factor in advanced-stage …
to EGFR-tyrosine kinase inhibitor and an advantageous prognostic factor in advanced-stage …
The impact of epidermal growth factor receptor mutations on the prognosis of resected non-small cell lung cancer: a meta-analysis of literatures
Q He, P Xin, M Zhang, S Jiang… - Translational lung …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Epidermal growth factor receptor (EGFR) mutation represents a good response
to EGFR-tyrosine kinase inhibitor and an advantageous prognostic factor in advanced-stage …
to EGFR-tyrosine kinase inhibitor and an advantageous prognostic factor in advanced-stage …
The impact of epidermal growth factor receptor mutations on the prognosis of resected non-small cell lung cancer: a meta-analysis of literatures.
Q He, P Xin, M Zhang, S Jiang, J Zhang… - Translational Lung …, 2019 - europepmc.org
Background Epidermal growth factor receptor (EGFR) mutation represents a good response
to EGFR-tyrosine kinase inhibitor and an advantageous prognostic factor in advanced-stage …
to EGFR-tyrosine kinase inhibitor and an advantageous prognostic factor in advanced-stage …
[引用][C] The impact of epidermal growth factor receptor mutations on the prognosis of resected non-small cell lung cancer: a meta-analysis of literatures
Q He, P Xin, M Zhang, S Jiang, J Zhang… - … Lung Cancer Research, 2019 - cir.nii.ac.jp
The impact of epidermal growth factor receptor mutations on the prognosis of resected non-small
cell lung cancer: a meta-analysis of literatures | CiNii Research CiNii 国立情報学研究所 学術 …
cell lung cancer: a meta-analysis of literatures | CiNii Research CiNii 国立情報学研究所 学術 …
[PDF][PDF] The impact of epidermal growth factor receptor mutations on the prognosis of resected non-small cell lung cancer: a meta-analysis of literatures
Q He, P Xin, M Zhang, S Jiang, J Zhang, S Zhong, Y Liu… - cdn.amegroups.cn
Background: Epidermal growth factor receptor (EGFR) mutation represents a good response
to EGFR-tyrosine kinase inhibitor and an advantageous prognostic factor in advanced-stage …
to EGFR-tyrosine kinase inhibitor and an advantageous prognostic factor in advanced-stage …
[HTML][HTML] The impact of epidermal growth factor receptor mutations on the prognosis of resected non-small cell lung cancer: a meta-analysis of literatures
Q He, P Xin, M Zhang, S Jiang, J Zhang… - Translational Lung …, 2019 - tlcr.amegroups.org
Background: Epidermal growth factor receptor (EGFR) mutation represents a good response
to EGFR-tyrosine kinase inhibitor and an advantageous prognostic factor in advanced-stage …
to EGFR-tyrosine kinase inhibitor and an advantageous prognostic factor in advanced-stage …
The impact of epidermal growth factor receptor mutations on the prognosis of resected non-small cell lung cancer: a meta-analysis of literatures.
Q He, P Xin, M Zhang, S Jiang, J Zhang… - Translational Lung …, 2019 - europepmc.org
Background Epidermal growth factor receptor (EGFR) mutation represents a good response
to EGFR-tyrosine kinase inhibitor and an advantageous prognostic factor in advanced-stage …
to EGFR-tyrosine kinase inhibitor and an advantageous prognostic factor in advanced-stage …